Discordance: Can we capitalize on it to better personalize atherosclerosis treatment?

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 504-506

  Nasir, Khurram ^a,b,c,d   Martin, Seth S ^d   Virani, Salim ^e,f  

^a Baptist Health South Florida   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary artery calcium; Lipids; Risk; Subclinical atherosclerosis

Indexed keywords

APOLIPOPROTEIN B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; NOTE; PRIORITY JOURNAL;

CORONARY ARTERY CALCIUM; LIPIDS; RISK; SUBCLINICAL ATHEROSCLEROSIS;

ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; ETHNIC GROUPS; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; VASCULAR CALCIFICATION;

EID: 84880623629     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.04.018     Document Type: Note

References (24)

1. Brown M., Goldstein J.L. How LDL receptors influence cholesterol and atherosclerosis. Sci Am 1984, 251:58-66.
2. Keys A. Seven countries: a multivariate analysis of death and coronary heart disease 1980, l-381. Harvard University Press, Cambridge, MA.
3. Kannel W.B., Castelli W.P., Gordon T., McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham study. Ann Intern Med 1971, 74:1-12.
4. Lewington S., Whitlock G., Clarke R., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839.
5. Baigent C., Blackwell L., Emberson J., et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010, 376:1670-1681.
6. Orakzai S.H., Nasir K., Blaha M., Blumenthal R.S., Raggi P. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis 2009, 202:289-295.
7. Virani S.S., Pompeii L., Lincoln A.E., et al. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis 2012, 222:551-556.
8. Miname M.H., Ribeiro M.S., Parga Filho J., et al. Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia. Atherosclerosis 2010, 213:486-491.
9. Blankstein R., Budoff M.J., Shaw L.J., et al. Predictors of coronary heart disease events among asymptomatic individuals with low LDL: the multi-ethnic study of atherosclerosis. JAm Coll Cardiol 2011, 58:364-574.
10. Martin S.S., Blaha M.J., Elshazly M.B., et al. Friedewald estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. JAm Coll Cardiol 2013, [Epub ahead of print].
11. McQueen M.J., Hawken S., Wang X., et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008, 372:224-233. INTERHEART study investigators.
12. deGoma E.M., Davis M.D., Dunbar R.L., Mohler E.R., Greenland P., French B. Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the multi-ethnic study of atherosclerosis. Atherosclerosis 2013, 229(2):517-523.
13. Erbel R., Lehmann N., Churzidse S., et al. Gender-specific association of coronary artery calcium and lipoprotein parameters: The Heinz Nixdorf Recall Study. Atherosclerosis 2013, 229(2):531-540.
14. Catapano A.L., Reiner Z., De Backer G., et al. European Society of Cardiology (ESC), European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011, 217:3-46.
15. Executive Summary of the Third Report of the National cholesterol Education Program (NCEP) expert Panel on detection, evaluation, and treatment of high blood cholesterol in Adults (Adult treatment Panel III). JAMA 2001, 285(19):2486-2497.
16. Nasir K., Shaw L.J., Budoff M.J., Ridker P.M., Peña J.M. Coronary artery calcium scanning should be used for primary prevention: pros and cons. JACC Cardiovasc Imaging 2012, 5:111-118.
17. Hayward R.A., Krumholz H.M. Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health. Circ Cardiovasc Qual Outcome 2012, 5:2-5.
18. Detrano R., Guerci A.D., Carr J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. NEngl J Med 2008, 358:1336-1345.
19. Erbel R., Möhlenkamp S., Moebus S., et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis. The Heinz Nixdorf Recall Study. JAm Coll Cardiol 2010, 56:1397-1406. Heinz Nixdorf Recall Study Investigative Group.
20. Yeboah J., McClelland R.L., Polonsky T.S., et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012 Aug 22, 308:788-795.
21. Sarwar A., Shaw L.J., Shapiro M.D., et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging 2009, 2:675-688.
22. Blaha M.J., Budoff M.J., Shaw L.J., et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging 2009, 2:692-700.
23. Budoff M.J., McClelland R.L., Nasir K., et al. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2009, 158:554-561.
24. Madanieh R., Hasan R.K., Anusionwu O.F., Blumenthal R.S., Blaha M.J. Cardiovascular disease prevention: matching evidence-based algorithms with individualized care. Clin Pharmacol Ther 2013, 93:321-323.